SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (4657)4/23/1998 3:46:00 PM
From: biowa  Read Replies (1) of 9719
 
Henry,

>>I have a quick version of the table listing compounds in their pipeline at home.att.net;

Thanks for the excellent resource; as we all agree, LGND has an exciting pipeline/future. One thing I noticed on your table, was that all of the progesterone agonist/antagonist projects show no progress in 1997. Have they hit a wall? In the wake of the Evista hoopla, I've talked with several people, who say that's great for those with estrogen-sensitive or e/p-sensitive breast cancer but feel that those with progesterone-sensitive disease are being left behind. If LGND and partners are continuing to develop candidates in this area that could be a very interesting area. What do you know about this?

Once again, thanks.

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News